{
    "hands_on_practices": [
        {
            "introduction": "A cornerstone of neurotrophin biology is the principle of specificity, where distinct neuronal populations depend on particular neurotrophin-receptor pairs for survival and function. This first exercise provides a classic scenario to test your understanding of this fundamental rule. By determining the correct survival factor for a specific type of neuron, you will practice applying your knowledge of which neurotrophin binds to which high-affinity receptor to elicit a pro-survival signal .",
            "id": "2354217",
            "problem": "A neurobiologist is working with a primary culture of post-ganglionic sympathetic neurons isolated from an embryonic mammal. It is well-established that these neurons require continuous trophic support to survive; in its absence, they rapidly undergo apoptosis (programmed cell death). The pro-survival signaling in this specific neuronal population is known to be mediated primarily through the high-affinity activation of the Tropomyosin receptor kinase A (TrkA) receptor. The neurobiologist aims to promote the long-term viability of this culture by supplementing the growth medium with a single, purified agent.\n\nWhich one of the following agents, when added to the culture medium, would be the most effective choice for promoting the survival of these cultured sympathetic neurons?\n\nA. Nerve Growth Factor (NGF)\n\nB. Brain-Derived Neurotrophic Factor (BDNF)\n\nC. Neurotrophin-3 (NT-3)\n\nD. A function-blocking antibody against the p75 neurotrophin receptor (p75NTR)\n\nE. A synthetic ligand that specifically activates the p75 neurotrophin receptor (p75NTR)",
            "solution": "The problem asks for the most effective agent to promote the survival of post-ganglionic sympathetic neurons in culture. The key piece of information provided is that survival in these neurons is mediated by the Tropomyosin receptor kinase A (TrkA) receptor. Therefore, the solution is to identify the agent that specifically binds to and activates the TrkA receptor with high affinity.\n\nStep 1: Analyze the fundamental requirement for survival.\nThe neurons require an active pro-survival signal, which is initiated by the activation of the TrkA receptor. This activation triggers downstream intracellular signaling cascades (such as the PI3K-Akt pathway and the Ras-MAPK pathway) that suppress the apoptotic machinery and promote gene expression related to cell survival and maintenance.\n\nStep 2: Evaluate each option based on its interaction with the neurotrophin receptor system.\n\nOption A: Nerve Growth Factor (NGF)\nNGF is the canonical and high-affinity ligand for the TrkA receptor. The binding of NGF to TrkA causes the receptor to dimerize and autophosphorylate, leading to the robust activation of the pro-survival pathways mentioned in Step 1. Since the problem explicitly states that sympathetic neurons rely on TrkA for survival, NGF is the most direct and effective agent to provide this signal.\n\nOption B: Brain-Derived Neurotrophic Factor (BDNF)\nBDNF is another member of the neurotrophin family, but its primary high-affinity receptor is the Tropomyosin receptor kinase B (TrkB). Post-ganglionic sympathetic neurons are characterized by high expression of TrkA, not TrkB. Therefore, adding BDNF to the culture would not lead to significant receptor activation and would be ineffective at promoting their survival.\n\nOption C: Neurotrophin-3 (NT-3)\nNT-3's primary high-affinity receptor is the Tropomyosin receptor kinase C (TrkC), which is typically expressed by other neuronal populations like proprioceptive sensory neurons. While NT-3 does exhibit some promiscuity and can bind to TrkA and TrkB, it does so with a much lower affinity than their respective primary ligands (NGF for TrkA, BDNF for TrkB). Consequently, NT-3 would be a much less potent and effective survival factor for TrkA-dependent sympathetic neurons compared to NGF.\n\nOption D: A function-blocking antibody against the p75 neurotrophin receptor (p75NTR)\nThe p75 neurotrophin receptor (p75NTR) is a \"common\" neurotrophin receptor that can be bound by all neurotrophins. Its signaling outcome is context-dependent. In the absence of Trk receptor signaling, p75NTR activation can initiate apoptosis. Therefore, blocking p75NTR might seem beneficial as it could prevent this potential death signal. However, this is a passive approach. It removes a potential \"kill\" signal but does not provide the positive \"survive\" signal that the neurons actively require from TrkA activation. Without the active pro-survival signaling from TrkA, the neurons would still likely undergo apoptosis, albeit perhaps more slowly.\n\nOption E: A synthetic ligand that specifically activates the p75 neurotrophin receptor (p75NTR)\nActivating p75NTR in the absence of a strong, concurrent signal from a Trk receptor is well-documented to induce apoptosis in many neuronal types, including sympathetic neurons. Therefore, adding a substance that specifically activates p75NTR would be counterproductive and would likely accelerate the death of the cultured neurons rather than promote their survival.\n\nStep 3: Conclude the analysis.\nBased on the specific receptor-ligand pairings and their functional outcomes, NGF is the only agent listed that directly and potently activates the TrkA receptor, which is the essential mediator of survival for sympathetic neurons. Thus, it is the most effective choice.",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "Beyond knowing which ligand binds which receptor, a quantitative understanding of this interaction is critical for both basic research and drug development. This practice moves from a qualitative concept to a quantitative analysis, challenging you to work with experimental data. By analyzing a saturation binding experiment, you will estimate the equilibrium dissociation constant ($K_{d}$), a measure of binding affinity, and the maximal binding capacity ($B_{\\max}$), which reflects the total number of receptors .",
            "id": "5045571",
            "problem": "A saturation binding experiment was performed using Brain-Derived Neurotrophic Factor (BDNF) binding to the tropomyosin receptor kinase B receptor (TrkB) in cultured hippocampal neurons. Specific binding was quantified at equilibrium as femtomoles of ligand bound per milligram of membrane protein. The free ligand concentration in the bath was approximated as equal to the added BDNF concentration because cellular depletion was negligible relative to the bath volume. Assume a single class of non-cooperative binding sites obeying the law of mass action.\n\nMeasured data (free ligand concentration $[L]$ in $\\mathrm{nM}$; specific bound $B$ in $\\mathrm{fmol/mg}$):\n- $[L] = 0.10$, $B = 1.10$\n- $[L] = 0.30$, $B = 2.75$\n- $[L] = 0.70$, $B = 4.95$\n- $[L] = 1.50$, $B = 7.15$\n- $[L] = 3.00$, $B = 8.95$\n- $[L] = 7.00$, $B = 10.60$\n- $[L] = 10.00$, $B = 10.90$\n\nUsing only first principles and the definition of the equilibrium dissociation constant, derive the appropriate binding relation and estimate the equilibrium dissociation constant $K_{d}$ (in $\\mathrm{nM}$) and the maximal binding capacity $B_{\\max}$ (in $\\mathrm{fmol/mg}$) for TrkB under these conditions. Then, compare your estimated $K_{d}$ to a representative literature value for high-affinity BDNF–TrkB binding in hippocampal neurons, $K_{d,\\mathrm{lit}} = 0.80\\,\\mathrm{nM}$, by computing the fold difference\n$$\nR = \\frac{K_{d}}{K_{d,\\mathrm{lit}}}.\n$$\nReport $R$ as a dimensionless decimal. Round your final value of $R$ to three significant figures. Express $K_{d}$ in $\\mathrm{nM}$ and $B_{\\max}$ in $\\mathrm{fmol/mg}$ in your working, but the final reported $R$ must be unitless.",
            "solution": "The problem statement is evaluated to be valid. It is scientifically grounded in the principles of receptor-ligand binding, well-posed with sufficient data for a unique statistical solution, and objective in its language. The experimental context, neurotrophin signaling via TrkB receptors, is a standard topic in neurobiology, and the provided data and literature values are realistic. The task is a standard data analysis problem involving parameter estimation from experimental data.\n\nThe relationship between the specifically bound ligand, $B$, the free ligand concentration, $[L]$, the equilibrium dissociation constant, $K_d$, and the maximal binding capacity, $B_{\\max}$, can be derived from first principles using the law of mass action. The binding of a ligand $L$ to a single class of non-cooperative receptors $R$ to form a complex $LR$ is represented by the reversible reaction:\n$$\nL + R \\rightleftharpoons LR\n$$\nAt equilibrium, the dissociation constant $K_d$ is defined by the ratio of the product of the concentrations of the reactants to the concentration of the product:\n$$\nK_d = \\frac{[L][R]}{[LR]}\n$$\nwhere $[L]$ is the concentration of free ligand, $[R]$ is the concentration of free receptors, and $[LR]$ is the concentration of the ligand-receptor complex.\n\nThe total concentration of receptors, $[R]_T$, is the sum of free and bound receptors:\n$$\n[R]_T = [R] + [LR]\n$$\nThe experimentally measured specific binding, $B$, is directly proportional to the concentration of the ligand-receptor complex, $[LR]$. The maximal binding capacity, $B_{\\max}$, is proportional to the total receptor concentration, $[R]_T$. Thus, we can write:\n$$\n\\frac{B}{B_{\\max}} = \\frac{[LR]}{[R]_T}\n$$\nFrom the definition of $K_d$, we can express the free receptor concentration as $[R] = \\frac{K_d [LR]}{[L]}$. Substituting this into the equation for total receptor concentration gives:\n$$\n[R]_T = \\frac{K_d [LR]}{[L]} + [LR] = [LR] \\left( \\frac{K_d}{[L]} + 1 \\right) = [LR] \\left( \\frac{K_d + [L]}{[L]} \\right)\n$$\nNow, we can substitute this expression for $[R]_T$ into the ratio for $B/B_{\\max}$:\n$$\n\\frac{B}{B_{\\max}} = \\frac{[LR]}{[LR] \\left( \\frac{K_d + [L]}{[L]} \\right)} = \\frac{[L]}{K_d + [L]}\n$$\nRearranging this gives the final binding isotherm, which is an equation of the Langmuir type (or Michaelis-Menten form):\n$$\nB = \\frac{B_{\\max} [L]}{K_d + [L]}\n$$\nTo estimate the parameters $K_d$ and $B_{\\max}$ from the provided data, we can linearize this equation. A common and robust linearization is the Scatchard transformation. We rearrange the binding isotherm as follows:\n$$\nB(K_d + [L]) = B_{\\max} [L] \\\\\nB K_d + B [L] = B_{\\max} [L] \\\\\nB K_d = (B_{\\max} - B) [L] \\\\\n\\frac{B}{[L]} = \\frac{B_{\\max} - B}{K_d} \\\\\n\\frac{B}{[L]} = -\\frac{1}{K_d} B + \\frac{B_{\\max}}{K_d}\n$$\nThis equation is in the form of a straight line, $y = mx + c$, where $y = \\frac{B}{[L]}$, $x = B$, the slope is $m = -\\frac{1}{K_d}$, and the y-intercept is $c = \\frac{B_{\\max}}{K_d}$.\n\nWe first transform the given $N=7$ data points $([L], B)$ into $(x, y) = (B, B/[L])$ pairs. The units for $B$ are $\\mathrm{fmol/mg}$ and for $[L]$ are $\\mathrm{nM}$. Therefore, the units for $B/[L]$ are $(\\mathrm{fmol/mg})/\\mathrm{nM}$.\n\\begin{itemize}\n    \\item For $([L], B) = (0.10, 1.10)$, $(x_1, y_1) = (1.10, 11.0)$\n    \\item For $([L], B) = (0.30, 2.75)$, $(x_2, y_2) = (2.75, 9.167)$\n    \\item For $([L], B) = (0.70, 4.95)$, $(x_3, y_3) = (4.95, 7.071)$\n    \\item For $([L], B) = (1.50, 7.15)$, $(x_4, y_4) = (7.15, 4.767)$\n    \\item For $([L], B) = (3.00, 8.95)$, $(x_5, y_5) = (8.95, 2.983)$\n    \\item For $([L], B) = (7.00, 10.60)$, $(x_6, y_6) = (10.60, 1.514)$\n    \\item For $([L], B) = (10.00, 10.90)$, $(x_7, y_7) = (10.90, 1.090)$\n\\end{itemize}\nWe perform a simple linear regression on these transformed data points. The required sums are:\n$$ \\sum_{i=1}^{7} x_i = 46.40 $$\n$$ \\sum_{i=1}^{7} y_i \\approx 37.592 $$\n$$ \\sum_{i=1}^{7} x_i^2 = 395.67 $$\n$$ \\sum_{i=1}^{7} x_i y_i \\approx 161.025 $$\nThe slope $m$ of the regression line is calculated as:\n$$ m = \\frac{N \\sum(x_i y_i) - (\\sum x_i)(\\sum y_i)}{N \\sum(x_i^2) - (\\sum x_i)^2} \\approx \\frac{7(161.025) - (46.40)(37.592)}{7(395.67) - (46.40)^2} $$\n$$ m \\approx \\frac{1127.175 - 1744.1728}{2769.69 - 2152.96} = \\frac{-616.9978}{616.73} \\approx -1.00043 $$\nThe y-intercept $c$ is calculated as $c = \\bar{y} - m\\bar{x}$:\n$$ \\bar{x} = \\frac{\\sum x_i}{N} = \\frac{46.40}{7} \\approx 6.6286 $$\n$$ \\bar{y} = \\frac{\\sum y_i}{N} \\approx \\frac{37.592}{7} \\approx 5.3703 $$\n$$ c \\approx 5.3703 - (-1.00043)(6.6286) \\approx 5.3703 + 6.6312 \\approx 12.0015 $$\nFrom the slope and intercept, we can estimate $K_d$ and $B_{\\max}$:\n$$ K_d = -\\frac{1}{m} \\approx -\\frac{1}{-1.00043} \\approx 0.99957\\,\\mathrm{nM} $$\n$$ B_{\\max} = c \\cdot K_d \\approx (12.0015) \\cdot (0.99957) \\approx 11.996\\,\\mathrm{fmol/mg} $$\nThe estimated values are $K_d \\approx 1.00\\,\\mathrm{nM}$ and $B_{\\max} \\approx 12.0\\,\\mathrm{fmol/mg}$.\n\nThe final step is to compute the fold difference $R$ between our estimated $K_d$ and the provided literature value, $K_{d,\\mathrm{lit}} = 0.80\\,\\mathrm{nM}$.\n$$ R = \\frac{K_{d}}{K_{d,\\mathrm{lit}}} \\approx \\frac{0.99957}{0.80} \\approx 1.2494625 $$\nRounding this value to three significant figures gives:\n$$ R \\approx 1.25 $$",
            "answer": "$$\\boxed{1.25}$$"
        },
        {
            "introduction": "Neurotrophic factors do more than simply keep neurons alive; they are powerful modulators of synaptic function and plasticity, the cellular basis of learning and memory. This final, integrative exercise asks you to predict how disrupting Brain-Derived Neurotrophic Factor (BDNF) signaling affects Long-Term Potentiation (LTP) and the structure of dendritic spines. This problem will challenge you to connect the molecular details of intracellular signaling cascades to complex, higher-order physiological and anatomical changes at the synapse .",
            "id": "5045628",
            "problem": "A postsynaptic neuron in hippocampal slice culture is transfected with a dominant-negative isoform of the Tropomyosin receptor kinase B (TrkB) receptor, TrkB.T1, which lacks the intracellular tyrosine kinase domain. Brain-Derived Neurotrophic Factor (BDNF) normally binds full-length TrkB, leading to receptor dimerization and autophosphorylation that engages three canonical pathways: Phospholipase C gamma (PLCγ), Phosphatidylinositol 3-kinase (PI3K)-Akt-mammalian target of rapamycin (mTOR), and Ras-Mitogen-Activated Protein Kinase (MAPK)-Extracellular signal-Regulated Kinase (ERK). Long-Term Potentiation (LTP) requires postsynaptic $\\mathrm{Ca}^{2+}$ entry through N-methyl-D-aspartate (NMDA) receptors, activation of calcium/calmodulin-dependent kinases, insertion of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, actin cytoskeleton remodeling in dendritic spines, and for long-lasting forms, new protein synthesis. Dendritic spine enlargement and stabilization depend on Rho family GTPases (for example, Rac1 and Cdc42) that promote actin polymerization. The truncated TrkB.T1 isoform can heterodimerize with full-length TrkB and bind ligand without signaling, thereby acting as a dominant-negative by preventing autophosphorylation and downstream pathway activation; TrkB.T1 has also been reported to alter Rho GTPase signaling via interactions with Rho guanine nucleotide dissociation inhibitor.\n\nAfter inducing LTP with high-frequency stimulation and imaging spines on the transfected neuron over several hours, which of the following is the most accurate prediction about the effect of postsynaptic TrkB.T1 expression on LTP and dendritic spine morphology, and what is the pathway basis for that prediction?\n\nA. LTP is enhanced and dendritic spines become larger mushroom-type structures because TrkB.T1 expression increases extracellular BDNF availability and augments presynaptic neurotransmitter release via facilitation of Ras-MAPK signaling.\n\nB. LTP magnitude and persistence are unchanged, but dendritic spines become fewer while maintaining normal head size because BDNF-TrkB signaling primarily affects morphology through Rho GTPases and does not contribute to synaptic potentiation.\n\nC. Early LTP is selectively impaired, but late LTP and spine enlargement are preserved because PLCγ inhibition reduces initial $\\mathrm{Ca}^{2+}$ mobilization while PI3K-mTOR-dependent protein synthesis compensates for maintenance.\n\nD. LTP is reduced in magnitude and less stable over time, and dendritic spines show decreased density with more thin, immature filopodia-like protrusions, because dominant-negative TrkB.T1 blocks TrkB autophosphorylation and downstream PLCγ, PI3K-Akt-mTOR, and Ras-MAPK-ERK signaling required for AMPA receptor insertion, local translation, and actin remodeling via Rac1/Cdc42.\n\nE. LTP remains normal but Long-Term Depression (LTD) is increased, accompanied by spine shrinkage, because TrkB.T1 preferentially activates RhoA-dependent actin depolymerization while leaving TrkB-dependent potentiation pathways intact.",
            "solution": "### Step 1: Extract Givens\n\nThe problem statement provides the following information:\n1.  **System:** A postsynaptic neuron in a hippocampal slice culture.\n2.  **Genetic Modification:** The neuron is transfected with `TrkB.T1`, a dominant-negative isoform of the Tropomyosin receptor kinase B (`TrkB`) receptor.\n3.  **Properties of `TrkB.T1`:**\n    -   Lacks the intracellular tyrosine kinase domain.\n    -   Binds the ligand, Brain-Derived Neurotrophic Factor (`BDNF`).\n    -   Can heterodimerize with full-length `TrkB` receptors.\n    -   Acts as a dominant-negative by preventing autophosphorylation and downstream pathway activation.\n    -   Reported to alter `Rho` GTPase signaling via interactions with `Rho` guanine nucleotide dissociation inhibitor (`RhoGDI`).\n4.  **Normal `BDNF`-`TrkB` Signaling:**\n    -   Binding of `BDNF` to full-length `TrkB` leads to receptor dimerization and autophosphorylation.\n    -   This activates three canonical downstream pathways:\n        -   Phospholipase C gamma (`PLCγ`)\n        -   Phosphatidylinositol $3$-kinase (`PI3K`)-`Akt`-mammalian target of rapamycin (`mTOR`)\n        -   `Ras`-Mitogen-Activated Protein Kinase (`MAPK`)-Extracellular signal-Regulated Kinase (`ERK`)\n5.  **Requirements for Long-Term Potentiation (`LTP`):**\n    -   Postsynaptic `\\mathrm{Ca}^{2+}` entry through N-methyl-D-aspartate (`NMDA`) receptors.\n    -   Activation of calcium/calmodulin-dependent kinases.\n    -   Insertion of alpha-amino-$3$-hydroxy-$5$-methyl-$4$-isoxazolepropionic acid (`AMPA`) receptors.\n    -   Actin cytoskeleton remodeling in dendritic spines.\n    -   For long-lasting forms of `LTP` (L-`LTP`): new protein synthesis.\n6.  **Requirements for Spine Morphology:**\n    -   Dendritic spine enlargement and stabilization depend on `Rho` family GTPases (e.g., `Rac1` and `Cdc42`) that promote actin polymerization.\n7.  **Experimental Condition:** `LTP` is induced using high-frequency stimulation (`HFS`), and dendritic spines on the transfected neuron are imaged for several hours.\n8.  **Question:** Predict the effect of postsynaptic `TrkB.T1` expression on `LTP` and dendritic spine morphology, and identify the underlying pathway basis.\n\n### Step 2: Validate Using Extracted Givens\n\nThe problem statement is a well-defined exercise in molecular neurobiology.\n-   **Scientifically Grounded:** The entire problem is based on established, fundamental principles of synaptic plasticity. The roles of `BDNF`, `TrkB` receptors, `NMDA`/`AMPA` receptors, `LTP`, dendritic spines, and the specified intracellular signaling cascades (`PLCγ`, `PI3K-Akt`, `Ras-MAPK`) are central, well-documented concepts in neuroscience. The use of a dominant-negative receptor (`TrkB.T1`) is a standard experimental strategy to probe pathway function. All premises are factually sound.\n-   **Well-Posed:** The problem describes a specific perturbation (expression of `TrkB.T1`) in a defined system (postsynaptic hippocampal neuron) under a specific condition (`HFS`-induced `LTP`) and asks for a predictable outcome on function (`LTP`) and structure (spine morphology). The provided information is sufficient to formulate a logical, evidence-based prediction. A unique and meaningful solution exists.\n-   **Objective:** The problem is phrased in precise, technical language, free from subjectivity or ambiguity.\n\nThe problem statement successfully passes validation against all criteria. It is scientifically sound, contains sufficient information, is well-posed, and objective. It does not violate any of the specified flaw categories.\n\n### Step 3: Derivation and Option Analysis\n\n**Derivation:**\n\nThe central manipulation is the expression of `TrkB.T1`, a dominant-negative receptor. As stated, `TrkB.T1` binds `BDNF` but lacks a kinase domain. By forming non-functional heterodimers with full-length `TrkB`, it prevents the trans-autophosphorylation necessary for receptor activation. The direct consequence is the blockade of all downstream signaling initiated by `BDNF`-`TrkB` binding.\n\nThe three blocked canonical pathways and their established roles in `LTP` are:\n1.  **`PLCγ` pathway:** This pathway generates inositol trisphosphate (`IP_3`) and diacylglycerol (`DAG`). `IP_3` mobilizes intracellular `\\mathrm{Ca}^{2+}` stores, amplifying the `\\mathrm{Ca}^{2+}` signal crucial for `LTP` induction. `DAG` activates Protein Kinase C (`PKC`), which contributes to the trafficking and insertion of `AMPA` receptors. Blocking this pathway would dampen the signaling required for the initial potentiation.\n2.  **`PI3K`-`Akt`-`mTOR` pathway:** This is a primary regulator of protein synthesis. `mTOR` controls the translation of specific mRNAs in dendrites, a process known as local protein synthesis, which is essential for the consolidation of `LTP` and the structural remodeling of spines that occurs over minutes to hours. This pathway also regulates `AMPA` receptor trafficking. Blocking this pathway would severely impair the late, stable phase of `LTP` and associated structural changes.\n3.  **`Ras`-`MAPK`-`ERK` pathway:** This pathway is a key link between synaptic activity and the nucleus, regulating the gene expression required for L-`LTP` (the form lasting many hours to days). It also contributes to local protein synthesis. Blocking this pathway further compromises the stability and persistence of `LTP`.\n\nRegarding spine morphology, the problem states that spine enlargement and stabilization depend on `Rho` family GTPases like `Rac1` and `Cdc42`, which promote actin polymerization. `BDNF`-`TrkB` signaling is known to activate `Rac1` and `Cdc42` (often through `PI3K`-dependent intermediates). Therefore, blocking `TrkB` signaling will inhibit the activation of these GTPases. This prevents the actin remodeling needed for spines to grow and mature into stable, mushroom-shaped structures following `HFS`. The additional information that `TrkB.T1` interacts with `RhoGDI` (which normally keeps `Rho` GTPases inactive) suggests another mechanism by which `TrkB.T1` can dysregulate actin dynamics, likely contributing to the overall inhibitory effect on spine growth.\n\n**Synthesis of Prediction:**\n-   **`LTP`:** By blocking all three major downstream pathways, `TrkB.T1` will impair `AMPA` receptor insertion, local protein synthesis, and gene expression. This will result in a reduction of both the initial magnitude of `LTP` and, even more profoundly, its long-term stability and persistence. `LTP` will be weaker and decay more quickly.\n-   **Spine Morphology:** The failure to activate `Rac1`/`Cdc42` and promote actin polymerization will prevent the structural consolidation of `LTP`. Spines will fail to enlarge and stabilize. Instead, they may appear as thin, immature, filopodia-like structures, or they may retract over the observation period, leading to a net decrease in spine density.\n\n**Option-by-Option Analysis:**\n\n**A. LTP is enhanced and dendritic spines become larger mushroom-type structures because TrkB.T1 expression increases extracellular BDNF availability and augments presynaptic neurotransmitter release via facilitation of Ras-MAPK signaling.**\n-   This option claims an enhancement of `LTP` and spine growth. This is the opposite of the expected effect of a dominant-negative receptor. `TrkB.T1` *blocks*, not facilitates, `Ras-MAPK` signaling. The effect is postsynaptic, not primarily presynaptic.\n-   **Verdict:** Incorrect.\n\n**B. LTP magnitude and persistence are unchanged, but dendritic spines become fewer while maintaining normal head size because BDNF-TrkB signaling primarily affects morphology through Rho GTPases and does not contribute to synaptic potentiation.**\n-   This option incorrectly claims that `LTP` magnitude and persistence are unchanged. The premise that `BDNF`-`TrkB` signaling does not contribute to synaptic potentiation is factually wrong; it is a critical component, especially for L-`LTP`. The functional and structural aspects of plasticity are coupled, not independent.\n-   **Verdict:** Incorrect.\n\n**C. Early LTP is selectively impaired, but late LTP and spine enlargement are preserved because PLCγ inhibition reduces initial Ca²⁺ mobilization while PI3K-mTOR-dependent protein synthesis compensates for maintenance.**\n-   This option incorrectly suggests a selective impairment. `TrkB.T1` blocks all three major pathways, not just `PLCγ`. Crucially, it claims late `LTP` and spine enlargement are preserved, which is false because the very pathways required for these processes (`PI3K-mTOR`, `Ras-MAPK`) are inhibited. The idea of compensation is nonsensical as the compensatory pathway is itself blocked.\n-   **Verdict:** Incorrect.\n\n**D. LTP is reduced in magnitude and less stable over time, and dendritic spines show decreased density with more thin, immature filopodia-like protrusions, because dominant-negative TrkB.T1 blocks TrkB autophosphorylation and downstream PLCγ, PI3K-Akt-mTOR, and Ras-MAPK-ERK signaling required for AMPA receptor insertion, local translation, and actin remodeling via Rac1/Cdc42.**\n-   This option aligns perfectly with the derived prediction. It correctly describes the negative impact on both the magnitude and stability of `LTP`. It accurately predicts the morphological phenotype of impaired spine maturation (thin, immature protrusions, decreased density). It correctly identifies the mechanism: blocking `TrkB` autophosphorylation and all three downstream pathways (`PLCγ`, `PI3K-Akt-mTOR`, `Ras-MAPK-ERK`). Finally, it correctly links these pathways to the cellular processes they control (`AMPA` receptor insertion, local translation, and actin remodeling).\n-   **Verdict:** Correct.\n\n**E. LTP remains normal but Long-Term Depression (LTD) is increased, accompanied by spine shrinkage, because TrkB.T1 preferentially activates RhoA-dependent actin depolymerization while leaving TrkB-dependent potentiation pathways intact.**\n-   This option incorrectly states that `LTP` remains normal and that potentiation pathways are intact. This contradicts the fundamental action of a dominant-negative receptor. While `TrkB` signaling can oppose `LTD`, and its blockade might facilitate `LTD`-like processes, this option's primary claims are false. The idea that `TrkB.T1` *actively* and *preferentially* signaling is a gain-of-function hypothesis, contrary to its definition as a kinase-dead, dominant-negative construct.\n-   **Verdict:** Incorrect.",
            "answer": "$$\\boxed{D}$$"
        }
    ]
}